HomeBOT • ASX
add
Botanix Pharmaceuticals Ltd
Nakaraang pagsara
$0.15
Sakop ng araw
$0.14 - $0.15
Sakop ng taon
$0.11 - $0.54
Market cap
286.36M AUD
Average na Volume
8.86M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.71M | 219.92% |
Gastos sa pagpapatakbo | 26.90M | 618.83% |
Net na kita | -27.75M | -560.61% |
Net profit margin | -1.03K | -106.50% |
Kita sa bawat share | — | — |
EBITDA | -24.90M | -492.72% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 64.97M | -18.08% |
Kabuuang asset | 129.10M | 14.79% |
Kabuuang sagutin | 47.80M | 1,180.69% |
Kabuuang equity | 81.30M | — |
Natitirang share | 1.96B | — |
Presyo para makapag-book | 3.75 | — |
Return on assets | -49.33% | — |
Return on capital | -77.17% | — |
Cash Flow
Net change in cash
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -27.75M | -560.61% |
Cash mula sa mga operasyon | -24.01M | -999.67% |
Cash mula sa pag-invest | -97.95K | 93.92% |
Cash mula sa financing | 32.48M | -4.95% |
Net change in cash | 8.26M | -72.90% |
Malayang cash flow | -9.59M | -245.54% |
Tungkol
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Itinatag
1984
Website
Mga Empleyado
11
